![Kein Bild](https://static.cymitquimica.com/public/img/logo-cymit-gray.png)
CAS 706808-37-9: CTLA-4 (antigen)[29-tyrosine,104-glutamic acid] (human extracellular domain-containingfragment) fusion protein with immunoglobulin G1 (human monoclonal Fcdomain-containing fragment), bimol. (120®120')-disulfide (9CI)
- Synonyme:
- LEA 29Y
- BMS224818
- Belatacept
Marke | Produktdaten | Reinheit | Preisklasse | Voraussichtliche Lieferung |
---|---|---|---|---|
![]() | Belatacept REF: TM-T64239CAS: 706808-37-9 | - - - | 1.444,00 €~2.375,00 € | Mo 02 Jun 25 |
![discount label](https://static.cymitquimica.com/public/img/discount.png)
Belatacept
CAS:706808-37-9
Belatacept (BMS 224818), a T-cell costimulation inhibitor, targets CD80/86 for transplant immunosuppression.
Farbe und Form:
Liquid
Ref: TM-T64239
25mg | 1.444,00 € | ||
50mg | 1.882,00 € | ||
100mg | 2.375,00 € |
Voraussichtliche Lieferung in Vereinigte Staaten, am Montag 2. Juni 2025